Roche (ROG) vs AstraZeneca (AZN)
Roche (ROG) and AstraZeneca (AZN) side by side: both in Healthcare, listed on SIX Swiss Exchange and London Stock Exchange. Roche is the larger of the two by approximate market capitalization (about 1.1×).
| Field | Roche | AstraZeneca |
|---|---|---|
| Legal name | Roche Holding AG | AstraZeneca PLC |
| Ticker | ROG | AZN |
| Exchange | SIX Swiss Exchange XSWX | London Stock Exchange XLON |
| Jurisdiction | Switzerland | United Kingdom |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals and diagnostics | Pharmaceuticals |
| Market cap ≈ | $260bn | $230bn |
| Founded | 1896 | 1999 |
| Reporting currency | CHF | GBP |
| LEI | 549300U41AUUVOAAOB37 | PY6ZZQWO2IZFZC3IOL08 |
| ISIN | CH0012032048 | GB0009895292 |
| FIGI | BBG001SD12S2 | BBG001SCNW31 |
| Index membership | — | FTSE 100 |
| Held by (covered funds) | — | — |
Roche
Basel-based healthcare group founded in 1896, the world leader in in-vitro diagnostics and a top oncology drugmaker. The founding Hoffmann and Oeri families still hold a controlling voting stake.
AstraZeneca
Anglo-Swedish pharmaceutical company formed by the 1999 merger of Astra AB and Zeneca Group, with major franchises in oncology, cardiovascular and rare diseases. One of the largest companies on the London Stock Exchange.
Approximate reference values (seed-0.6 · 2026-08-29) — not real-time, not investment advice. Both sides as data: /api/v1/companies/roche · /api/v1/companies/astrazeneca